Kirk L Cumpston
Overview
Explore the profile of Kirk L Cumpston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tobarran N, Kershner E, Cumpston K, Chambers A, Michienzi A, Rose S, et al.
J Clin Psychopharmacol
. 2025 Feb;
45(2):92-95.
PMID: 39919308
Purpose/background: The antipsychotic class of medications has a varying degree of peripheral alpha antagonism resulting vasodilation and potentially hypotension. These hemodynamic changes may require treatment with crystalloids and vasopressors. The...
2.
Dong C, Oyekanmi O, Deuell Z, Chambers A, Kershner E, Rose S, et al.
Am J Emerg Med
. 2024 Dec;
89:24-26.
PMID: 39689629
Background: Superabsorbent polymers (SAPs) are hydrophilic polymers that expand many-fold from their original size after contact with water. Ingestions of "water beads" by young children have been reported to cause...
3.
Oyekanmi O, Dong C, Wills B, Cumpston K
Clin Toxicol (Phila)
. 2024 May;
62(4):267-268.
PMID: 38738682
Introduction: There has been a previous case report of peri-arrest muscle rigidity in the setting of severe salicylate poisoning (serum salicylate concentration 1,500 mg/L), described as paratonia or rapid rigor...
4.
Wilks M, Hoyte C, Cumpston K, Hassanian-Moghaddam H, Tse M, Ferrer-Dufol A, et al.
Clin Toxicol (Phila)
. 2024 Mar;
62(2):76-81.
PMID: 38465693
Introduction: Scientific societies aim to provide a collective voice and unified stance on important issues. The Clinical Toxicology Recommendations Collaborative was formed in 2016 to develop evidence- and consensus-based recommendations...
5.
Ochalek T, Ringwood K, Davis T, Gal T, Wills B, Sabo R, et al.
Drug Alcohol Depend Rep
. 2023 Apr;
7:100144.
PMID: 37033158
Background: Buprenorphine treatment has been associated with reduced non-prescribed opioid use and opioid related overdose (OD). We evaluated initial outcomes of rapid induction onto extended-release injectable buprenorphine (BUP-XR) within 7...
6.
Williams G, Downs J, Wolf C, Cumpston K, Tobarran N, Wills B, et al.
J Appl Lab Med
. 2023 Jan;
8(2):307-318.
PMID: 36705074
Background: Bone health supplements containing strontium are available without prescription, however, the effects of strontium interference on clinical laboratory calcium measurement procedures are unknown. Methods: To evaluate strontium interference on...
7.
Kershner E, Tobarran N, Chambers A, Jenkins Z, Wills B, Cumpston K
Am J Health Syst Pharm
. 2022 Dec;
80(8):526-531.
PMID: 36546397
Purpose: Dexmedetomidine is a central α2 agonist commonly used on intubated patients. It is increasingly being used off-label in nonintubated agitated patients. We sought to determine the overall clinical course,...
8.
Kershner E, Tobarran N, Chambers A, Wills B, Cumpston K
Clin Toxicol (Phila)
. 2022 Sep;
60(10):1176-1186.
PMID: 36074021
Introduction: Lead toxicity secondary to retained bullet(s) (RB) after a penetrating gunshot wound is a rare but likely underdiagnosed condition, given the substantial number of firearm injuries in the United...
9.
Tobarran N, Kershner E, Chambers A, Cumpston K, Wills B
Am J Emerg Med
. 2022 Jul;
59:218.e5-218.e6.
PMID: 35835657
Brimonidine is a topical ophthalmic alpha-2 adrenergic agonist solution used to treat glaucoma. The toxidrome includes drowsiness, lethargy, hypotension, bradycardia, and respiratory depression when ingested in infants. We report a...
10.
Cumpston K, Rodriguez V, Nguyen T, Maclasco A, Zin C, Rose S, et al.
Am J Emerg Med
. 2022 Apr;
58:323-324.
PMID: 35361517
No abstract available.